Skip to content

13F-HR filed by PRINCIPAL FINANCIAL GROUP INC

PRINCIPAL FINANCIAL GROUP INC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-09, with 2,539 holding rows worth $158,567,827,000.

Accession
0001126328-22-000046
Filed
2022-05-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A combination report, 4,055 entries on the cover page, a total value of $158,567,827,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $158,567,827,000 with VALUE read as thousands by filing date, 13F file number 028-10106. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerOrigin Asset Management, LLP 028-13785
  • reports for this filerPost Advisory Group, LLC 028-12454
  • reports for this filerSpectrum Asset Management, Inc 028-11300
  • included managerPrincipal Global Investors, LLC 028-01549
  • included managerPrincipal Real Estate Investors, LLC 028-10400
  • included managerPrincipal Life Insurance Co 028-00793
  • included managerPrincipal Financial Services, Inc 028-10107
  • included managerDelaware Charter Guarantee & Trust Company

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VELODYNE LIDAR INC92259F101COM13,838$35,000thousands by filing date
SESEN BIO INC817763105COM59,249$35,000thousands by filing date
GERON CORP374163103COM24,028$33,000thousands by filing date
ASENSUS SURGICAL INC04367G103COM51,394$33,000thousands by filing date
VROOM INC92918V109COM12,111$32,000thousands by filing date
Atossa Therapeutics Inc04962H506Common Stock24,522$31,000thousands by filing date
TALKSPACE INC87427V103COM17,249$30,000thousands by filing date
CITIUS PHARMACEUTICALS INC17322U207COM16,538$30,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM26,504$30,000thousands by filing date
SOC TELEMED78472F101COM10,050$30,000thousands by filing date
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK10,811$29,000thousands by filing date
NORDIC AMERICAN TANKERS LIMIG65773106COM13,348$28,000thousands by filing date
ADMA BIOLOGICS INC000899104COM15,041$28,000thousands by filing date
ARDELYX INC039697107COM26,870$28,000thousands by filing date
DURECT CORP266605104COM41,411$28,000thousands by filing date
SEELOS THERAPEUTICS INC81577F109COM29,894$25,000thousands by filing date
ROMEO POWER INC776153108COM16,115$24,000thousands by filing date
LIBERTY TRIPADVISOR HLDGS IN531465102COM SER A11,625$24,000thousands by filing date
GENIUS BRANDS INTERNATIONAL INC37229T301COMMON STOCK22,407$23,000thousands by filing date
SPRUCE POWER HOLDING CORP9837FR100COMMON STOCK11,099$22,000thousands by filing date
MARRONE BIO INNOVATIONS INC57165B106COM20,023$22,000thousands by filing date
ATHERSYS INC04744L106COM34,717$21,000thousands by filing date
ATHENEX INC04685N103COM23,397$19,000thousands by filing date
IBIO INC451033203COM NEW43,528$19,000thousands by filing date
TONIX PHARMACEUTICALS HOLDIN890260706COM78,945$18,000thousands by filing date
PAVMED INC70387R106COM13,342$18,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM13,446$18,000thousands by filing date
QUOTIENT LTDG73268107SHS14,597$18,000thousands by filing date
Ampio Pharmaceuticals03209T109COM36,770$17,000thousands by filing date
ASPIRA WOMENS HEALTH INC04537Y109COM14,194$15,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock11,117$15,000thousands by filing date
MEI PHARMA INC55279B202COM NEW23,217$14,000thousands by filing date
NEWAGE INC650194103COMMON STOCK16,996$10,000thousands by filing date
MUSTANG BIO INC62818Q104COM10,257$10,000thousands by filing date
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW16,872$10,000thousands by filing date
TREVENA INC89532E109COM16,715$9,000thousands by filing date
LIVEONE INC53814X102COM10,062$8,000thousands by filing date
TYME TECHNOLOGIES INC COM90238J103Stock19,514$7,000thousands by filing date
SURGALIGN HOLDINGS INC86882C105COM15,795$5,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001126328-22-000046this filing2022-05-09acceptance time not in the bulk data set